MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: An analysis of 50 cases on radical prostatectomy

Modern Pathology

Volumn 21, Issue 7, 2008, Pages 789-794

  Osunkoya, Adeboye O ^a   Adsay, N Volkan ^a   Cohen, Cynthia ^a   Epstein, Jonathan I ^b   Smith, Stacey L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

MUC2; Mucinous adenocarcinoma; Nonmucinous adenocarcinoma

Indexed keywords

MUCIN 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MUCINOUS CARCINOMA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; PROTEIN EXPRESSION;

EID: 46049118811     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.47     Document Type: Article

References (29)

1. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005;23:8146-8151.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
4. Grignon DJ. Unusual subtypes of prostate cancer. Mod Pathol 2004;17:316-327.
5. Cricco RP, Kassis J. Mucinous adenocarcinoma of prostate. Urology 1979;14:276-278.
6. Dhom G. Unusual prostatic carcinomas. Pathol Res Pract 1990;186:28-36.
7. Epstein JI, Lieberman PH. Mucinous adenocarcinoma of the prostate gland. Am J Surg Pathol 1985;9:299-308.
8. Olivas TP, Brady TW. Mucinous adenocarcinoma of the prostate: a report of a case of long-term survival. Urology 1996;47:256-258.
9. Rhee AC, Olgac S, Ohori M, et al. Mucinous adenocarcinoma of the prostate: a case report of long-term disease-free survival and a review of the literature. Urology 2004;63:779-780.
10. Osunkoya AO, Epstein JI. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases. Am J Surg Pathol 2007;31:1323-1329.
11. Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 2003;27:571-578.
12. Hanski C, Hofmeier M, Schmitt-Graff A, et al. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol 1997;182:385-391.
13. Siedow A, Szyf M, Gratchev A, et al. De novo expression of the Muc2 gene in pancreas carcinoma cells is triggered by promoter demethylation. Tumour Biol 2002;23:54-60.
14. Chambers JA, Hollingsworth MA, Trezise AE, et al. Developmental expression of mucin genes MUC1 and MUC2. J Cell Sci 1994;107:413-424.
15. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001;25:26-42.
16. Ho SB, Niehans GA, Lyftogt C, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993;53:641-651.
17. O'Connell JT, Shao ZM, Drori E, et al. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol 1998;29:1517-1523.
18. Luttges J, Zamboni G, Longnecker D, et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-948.
19. Saez C, Japon MA, Poveda MA, et al. Mucinous (colloid) adenocarcinomas secrete distinct o-acylated forms of sialomucins: a histochemical study of gastric, colorectal and breast adenocarcinomas. Histopathology 2001;39:554-560.
20. Velcich A, Yang W, Heyer J, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002;295:1726-1729.
21. McNeal JE, Alroy J, Villers A, et al. Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol 1991;22:979-988.
22. Teichman JM. Mucinous adenocarcinoma of the prostate: a report of a case of longterm survival. Urology 1996;48:660.
23. Lane BR, Magi-Galluzzi C, Reuther AM, et al. Mucinous adenocarcinoma of the prostate does not confer poor prognosis. Urology 2006;68:825-830.
24. Manne RK, Haddad FS. Mucinous adenocarcinoma of prostate. Urology 1989;33:247-249.
25. Randolph TL, Amin MB, Ro JY, et al. Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance. Mod Pathol 1997;10:612-629.
26. Skodras G, Wang J, Kragel PJ. Primary prostatic signet-ring cell carcinoma. Urology 1993;42:338-342.
27. Osunkoya AO, Nielson ME, Epstein JI. Prognosis of Mucinous Adenocarcinoma of the Prostate Treated by Radical Prostatectomy. A Study of 47 Cases. Am J Surg Pathol 2008;32:468-472.
28. Cappello F, Rappa F, David S, et al. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res 2003;23:1325-1331.
29. Cozzi PJ, Wang J, Delprado W, et al. MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clin Exp Metastasis 2005;22:565-573.